About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Illinois | 545 Studies

Clinical Trials Prostate CancerIllinois

Prostate Cancer Clinical Trials in Illinois

Find 545 clinical trials for prostate cancer near Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 221-240 of 545 trials

TerminatedNeoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate CancerThis trial will investigate the activity of dasatinib plus LHRH analogue therapy in high-risk localized prostate cancer.NCT00860158·Scottsdale, Arizona and 5 others UnknownThe Effect of IBD Flares on Serum PSAThis study will measure Prostate Specific Antigen (PSA) values in men with Inflammatory Bowel Disease (IBD) before, during, and following a flare.NCT03558048·Chicago, Illinois CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownA Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsThe purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage prostate cancer.NCT02225262·Normal, Illinois

CompletedIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following…NCT06604442·Phoenix, Arizona and 8 others

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedSU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: SU5416 may stop the growth of cancer by stopping blood flow to the tumor. Androgens can stimulate the growth of prostate cancer cells.NCT00026377·Chicago, Illinois and 2 others

CompletedA Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerVaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.NCT00108732·Jacksonville, Florida and 6 others

CompletedZoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyRATIONALE: Zoledronate may prevent bone loss in patients with prostate cancer undergoing radiation therapy and hormone therapy.NCT00329797·Chico, California and 87 others

CompletedIncreasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation TherapyThis trial studies how well increasing the dose of survivorship care planning improves care and outcomes in prostate cancer survivors receiving radiation therapy and androgen…NCT03860961·Kingman, Arizona and 78 others

CompletedXmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerThis Phase 2 study will investigate the safety and clinical activity of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with…NCT05005728·Anchorage, Alaska and 25 others

RecruitingGeriatric Assessment and Technology Evaluation in Prostate CancerBy doing this study, doctors hope to learn more about factors that contribute to frailty (a condition where older adults feel weak, get tired easily, and struggle more with…NCT06215508·Chicago, Illinois

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

TerminatedDecreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.Doctors leading this study plan to collect new information about the lowest effective dose of abiraterone acetate in study participants with prostate cancer who are taking…NCT05276492·Chicago, Illinois

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

CompletedAssessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenThe purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active…NCT00363311·Little Rock, Arkansas and 81 others

CompletedProstate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyDutasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT) the male hormone that leads to benign prostate growth.NCT00470834·Homewood, Alabama and 61 others

Active not recruitingAbiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsThis is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).NCT03012321·Los Angeles, California and 15 others

TerminatedStudy of HPN424 in Patients With Advanced Prostate CancerAn open-label, Phase 1/2a, study of HPN424 as monotherapy to assess the safety, tolerability and PK in patients with advanced prostate cancer refractory to androgen therapyNCT03577028·Los Angeles, California and 14 others

CompletedLycopene In Preventing of Prostate CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of lycopene may be an effective way to prevent prostate cancer.NCT00006078·Chicago, Illinois

PreviousPage 12 of 28Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma